Related Experiment Video
Updated: Aug 22, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Preparations for the Assessment of COVID-19 Infection and Long-Term Cardiovascular Risk
Jaehun Jung1,2
1Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
Insights
Long-COVID may increase cardiovascular risk, but its long-term effects require further study. South Korea is establishing a large cohort to gather real-world evidence on post-COVID conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Growing evidence links coronavirus disease 2019 (COVID-19) to increased cardiovascular disease (CVD) risk.
- The duration and magnitude of long-term cardiovascular risk following COVID-19 infection remain incompletely understood.
- Distinguishing acute complications from post-acute cardiovascular manifestations of COVID-19 is challenging, complicating the definition of Long-COVID.
Purpose of the Study:
- To establish a prospective cohort of COVID-19 survivors to investigate the long-term cardiovascular impact.
- To link COVID-19 cases with national health insurance data for comprehensive real-world evidence generation.
- To address the need for robust data on the long-term effects of SARS-CoV-2 infection, including potential Long-COVID conditions.
Main Methods:
- Establishment of a prospective cohort comprising 10,000 confirmed COVID-19 cases.
- Linking the COVID-19 cohort with claims data from the National Health Insurance Service (NHIS).
- Utilizing a new platform developed by the Korean government and KDCA for long-term impact assessment.
Main Results:
- The study is designed to accumulate significant real-world evidence on the long-term consequences of COVID-19.
- The cohort linkage aims to provide insights into the cardiovascular risks associated with COVID-19.
- Data will help clarify the prevalence and characteristics of post-acute COVID-19 conditions.
Conclusions:
- A robust prospective cohort linked to national claims data will enhance understanding of Long-COVID.
- This initiative is expected to yield critical real-world evidence on the long-term cardiovascular health of COVID-19 survivors.
- The findings will inform public health strategies and clinical management of post-COVID conditions.
Abstract:
Studies showing that coronavirus disease 2019 (COVID-19) is associated with an increased risk of cardiovascular disease continue to be published. However, studies on how long the overall cardiovascular risk increases after COVID-19 and the magnitude of its long-term effects have only been confirmed recently. This is partly because the distinction between cardiovascular risk as an acute complication of COVID-19 or post-acute cardiovascular manifestations is ambiguous. Long-COVID has arisen as an important topic in the second half of the pandemic. This term indicates that symptoms persist for more than two 2 months; following three months of SARS-CoV-2 infection and cannot be explained by other medical conditions. Despite the agreement of these international organizations and experts, it is difficult to define whether there is sufficient medical evidence to prove the existence of long-COVID. However, the Korean government and Korea Disease Control and Prevention Agency (KDCA) are preparing a new platform to assess the long-term impact of COVID-19. Using this data, a prospective cohort of 10,000 confirmed COVID-19 cases will be established. This cohort will be linked with claims data from the National Health Insurance Services (NHIS) and it is expected that increased real-world evidence of long-COVID will be accumulated.
More Related Videos
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management

